During the past decade, Retina Consultants of Southern California conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 8 clinical trials were completed, i.e. on average, 42.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Consultants of Southern California" #1 sponsor was "Kodiak Sciences Inc" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Jaeb Center for Health Research" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Consultants of Southern California" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Retina Consultants of Southern California" are "Diabetic Macular Edema" (7 trials), "Diabetic Retinopathy" (2 trials), "Geographic Atrophy" (2 trials), "Macular Degeneration" (2 trials) and "Macular Edema" (2 trials). Many other conditions were trialed in "Retina Consultants of Southern California" in a lesser frequency.

Most popular intervention types in "Retina Consultants of Southern California" are "Drug" (20 trials), "Other" (10 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (10 trials), "Aflibercept" (7 trials), "KSI-301" (5 trials), "Faricimab" (4 trials) and "Deferred aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Consultants of Southern California" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Retina Consultants of Southern California". undefined are not yet recruiting, 1 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Retina Consultants of Southern California, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Consultants of Southern California, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".